These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24331898)

  • 1. Operationalising the capability approach for outcome measurement in mental health research.
    Simon J; Anand P; Gray A; Rugkåsa J; Yeeles K; Burns T
    Soc Sci Med; 2013 Dec; 98():187-96. PubMed ID: 24331898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric validation of a multi-dimensional capability instrument for outcome measurement in mental health research (OxCAP-MH).
    Vergunst F; Jenkinson C; Burns T; Anand P; Gray A; Rugkåsa J; Simon J
    Health Qual Life Outcomes; 2017 Dec; 15(1):250. PubMed ID: 29282075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring broader wellbeing in mental health services: validity of the German language OxCAP-MH capability instrument.
    Łaszewska A; Schwab M; Leutner E; Oberrauter M; Spiel G; Simon J
    Qual Life Res; 2019 Aug; 28(8):2311-2323. PubMed ID: 31030365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of capability and health-related quality of life instruments in capturing aspects of mental well-being in people with schizophrenia and depression.
    Helter TM; Coast J; Łaszewska A; Stamm T; Simon J
    BJPsych Open; 2022 Jun; 8(4):e117. PubMed ID: 35758648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cultural and linguistic transferability of the multi-dimensional OxCAP-MH capability instrument for outcome measurement in mental health: the German language version.
    Simon J; Łaszewska A; Leutner E; Spiel G; Churchman D; Mayer S
    BMC Psychiatry; 2018 Jun; 18(1):173. PubMed ID: 29866092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the relative importance of the OxCAP-MH's capability items differ according to mental ill-health experience?
    Helter TM; Kaltenboeck A; Baumgartner J; Mayrhofer F; Heinze G; Sönnichsen A; Wancata J; Simon J
    Health Qual Life Outcomes; 2022 Jun; 20(1):99. PubMed ID: 35751092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost and quality-of-life impacts of community treatment orders (CTOs) for patients with psychosis: economic evaluation of the OCTET trial.
    Simon J; Mayer S; Łaszewska A; Rugkåsa J; Yeeles K; Burns T; Gray A
    Soc Psychiatry Psychiatr Epidemiol; 2021 Jan; 56(1):85-95. PubMed ID: 32719905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the EQ-5D measure quality of life in schizophrenia?
    Halling Hastrup L; Nordentoft M; Hjorthøj C; Gyrd-Hansen D
    J Ment Health Policy Econ; 2011 Dec; 14(4):187-96. PubMed ID: 22345360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intervention to improve the quality of life in children of parents with serious mental illness: the Young SMILES feasibility RCT.
    Abel KM; Bee P; Gega L; Gellatly J; Kolade A; Hunter D; Callender C; Carter LA; Meacock R; Bower P; Stanley N; Calam R; Wolpert M; Stewart P; Emsley R; Holt K; Linklater H; Douglas S; Stokes-Crossley B; Green J
    Health Technol Assess; 2020 Nov; 24(59):1-136. PubMed ID: 33196410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRIMSON [CRisis plan IMpact: Subjective and Objective coercion and eNgagement] protocol: a randomised controlled trial of joint crisis plans to reduce compulsory treatment of people with psychosis.
    Thornicroft G; Farrelly S; Birchwood M; Marshall M; Szmukler G; Waheed W; Byford S; Dunn G; Henderson C; Lester H; Leese M; Rose D; Sutherby K
    Trials; 2010 Nov; 11():102. PubMed ID: 21054847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of a specialist smoking cessation package compared with standard smoking cessation services for people with severe mental illness in England: a trial-based economic evaluation from the SCIMITAR+ study.
    Li J; Fairhurst C; Peckham E; Bailey D; Arundel C; Hewitt C; Heron P; Crosland S; Parrott S; Gilbody S;
    Addiction; 2020 Nov; 115(11):2113-2122. PubMed ID: 32319154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EQ-5D in alcohol dependent patients: relationships among health-related quality of life, psychopathology and social functioning.
    Günther O; Roick C; Angermeyer MC; König HH
    Drug Alcohol Depend; 2007 Jan; 86(2-3):253-64. PubMed ID: 16930855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing outcomes for cost-utility analysis in mental health interventions: mapping mental health specific outcome measure GHQ-12 onto EQ-5D-3L.
    Lindkvist M; Feldman I
    Health Qual Life Outcomes; 2016 Sep; 14(1):134. PubMed ID: 27644119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring refugees' capabilities: translation, adaptation, and valuation of the OxCAP-MH into Juba Arabic for use among South Sudanese male refugees in Uganda.
    van der Boor CF; Taban D; Ismail K; Simon J; Roberts B; Fuhr D; Tol WA; Greco G
    J Patient Rep Outcomes; 2024 Apr; 8(1):40. PubMed ID: 38564035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCT.
    Peckham E; Arundel C; Bailey D; Crosland S; Fairhurst C; Heron P; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C; Gilbody S
    Health Technol Assess; 2019 Sep; 23(50):1-116. PubMed ID: 31549622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR): a pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service.
    Peckham E; Man MS; Mitchell N; Li J; Becque T; Knowles S; Bradshaw T; Planner C; Parrott S; Michie S; Shepherd C; Gilbody S
    Health Technol Assess; 2015 Mar; 19(25):1-148, v-vi. PubMed ID: 25827850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience of the Time to Change programme in England as predictor of mental health service users' stigma coping strategies.
    Sampogna G; Bakolis I; Robinson E; Corker E; Pinfold V; Thornicroft G; Henderson C
    Epidemiol Psychiatr Sci; 2017 Oct; 26(5):517-525. PubMed ID: 27466083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying the Relationship between Capability and Health in Older People: Can't Map, Won't Map.
    Franklin M; Payne K; Elliott RA
    Med Decis Making; 2018 Jan; 38(1):79-94. PubMed ID: 29056069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are Quality-Adjusted Life Years a Good Proxy Measure of Individual Capabilities?
    Mitchell PM; Venkatapuram S; Richardson J; Iezzi A; Coast J
    Pharmacoeconomics; 2017 Jun; 35(6):637-646. PubMed ID: 28238151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.